(Q46462528)

22 December 2017

title

Mycophenolate mofetil: ten years' experience of a renal transplant unit (English)

1 reference

22 December 2017

author name string

S Jorge

1

1 reference

22 December 2017

J Guerra

2

1 reference

22 December 2017

A Santana

3

1 reference

22 December 2017

C Mil-Homens

4

1 reference

22 December 2017

M M Prata

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

22 December 2017

Transplantation Proceedings

published in

1 reference

22 December 2017

volume

40

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

700-704

1 reference

22 December 2017

The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Immunosuppression: practice and trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Six-year follow-up of azathioprine and mycophenolate mofetil use during the first 6 months of renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Clinical significance of protocol biopsy at one month posttransplantation in deceased-donor renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Protocol biopsies in renal transplantation: insights into patient management and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

Significance of protocol biopsies in living related renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.028

10.1016/J.TRANSPROCEED.2008.02.028

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017